Intraperitoneal chemotherapy during surgery for advanced ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a new way of combining chemotherapy and surgery to treat advanced ovarian, fallopian tube, or primary peritoneal cancer. It aims to see if giving chemotherapy directly into the abdomen during surgery (HIPEC) helps people live longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have a specific type of advanced ovarian, fallopian tube, or primary peritoneal cancer that cannot be removed with surgery at first, but may become removable after three chemotherapy sessions.
- You are healthy enough to have surgery and chemotherapy.
- You are not pregnant or breastfeeding.
- You have not had this type of surgery before (it is not for recurrent cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a heated chemotherapy treatment given in the abdomen during a planned second surgery (HIPEC) can improve outcomes for certain advanced ovarian cancers. It is for people who have already had initial chemotherapy and partially responded, with enough health to safely undergo surgery.
This trial studies whether adding a special heated chemotherapy treatment during surgery (called HIPEC) improves outcomes for some people with ovarian, fallopian tube, or primary peritoneal cancer. It compares surgery alone versus surgery plus HIPEC after you’ve had chemotherapy first.
This trial tests giving chemotherapy directly into the abdomen (intraperitoneal) after optimal surgery for advanced ovarian cancer. It aims to see if this approach is safe and effective for women who have already received 3-4 cycles of chemotherapy before surgery.
This study tests a treatment that uses heated chemotherapy directly in the belly (called hyperthermic intraperitoneal treatment) combined with an immunotherapy drug to see if it can make the immune therapy work better for advanced ovarian cancer.
This Phase 2 trial tests an intensive treatment for advanced ovarian, fallopian tube, or primary peritoneal cancer. It combines planned surgery to remove visible tumor with chemotherapy that is put directly inside the abdomen during the operation, aiming to control the cancer more effectively.
This trial studies a planned surgery to remove as much cancer as possible, followed by heated chemotherapy placed in the belly (called HIPEC). It’s for people with recurrent mucinous ovarian cancer, aiming to control the cancer and improve outcomes.
Hear when a new Ovary Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.